
Handbook of Biological Therapeutic Proteins
Regulatory, Manufacturing, Testing, and Patent Issues
- 412 pages
- English
- ePUB (mobile friendly)
- Available on iOS & Android
Handbook of Biological Therapeutic Proteins
Regulatory, Manufacturing, Testing, and Patent Issues
About this book
Since 1972, which marks the invention of recombinant engineering, more than 500 therapeutic proteins have been approved for clinical use. Today, biological drugs constitute almost 70% of all new drugs and have a biological origin. The first edition of this book dealt with biosimilars, and this edition (i.e., the second edition) focuses on new drugs, yet limits to therapeutic proteins. Newer technologies for drug development represent the updated topics in the book and include repur-posing, AI- driven identification of newer designs, novel expression systems, manufacturing using these systems, rapidly changing regulatory pathways, and legal hurdles. This edition discusses how to identify, develop, manufacture, and take multibillion dollar products to market within the shortest possible time.
Features:
- Complete and thorough coverage of the regulatory and technological challenges of developing generic therapeutic proteins
- Comprehensive, discovery to market, newer technologies, regulatory planning and IP hurdles are included that are not found elsewhere
- Expanded volume that must be in the hands of every company interested in biological drugs, including the mRNA-based biopharmaceutical companies fast appearing on the market
- Discusses how to identify, develop, manufacture, and take multibillion dollar products to market in the shortest possible time
- Renowned author and entrepreneur in the field of drug discovery and production
Frequently asked questions
- Essential is ideal for learners and professionals who enjoy exploring a wide range of subjects. Access the Essential Library with 800,000+ trusted titles and best-sellers across business, personal growth, and the humanities. Includes unlimited reading time and Standard Read Aloud voice.
- Complete: Perfect for advanced learners and researchers needing full, unrestricted access. Unlock 1.4M+ books across hundreds of subjects, including academic and specialized titles. The Complete Plan also includes advanced features like Premium Read Aloud and Research Assistant.
Please note we cannot support devices running on iOS 13 and Android 7 or earlier. Learn more about using the app.
Information
Table of contents
- Cover
- Half-Title Page
- Title Page
- Copyright Page
- Table of Contents
- Preface
- 1 Overview of the Development of Biosimilar Biopharmaceuticals
- 2 Regulatory Requirements for a Proposed Biosimilar Product
- 3 Development of a Master Plan for the Biosimilar
- 4 Trends in the Manufacturing of Recombinant Proteins
- 5 Analytical Assessment of a Biosimilar
- 6 Clinical Pharmacology Assessment of a Proposed Biosimilar
- 7 Clinical Immunogenicity Assessment of the Biosimilar
- 8 Clinical Efficacy Assessment of the Proposed Biosimilar
- 9 Recombinant Manufacturing System for Biopharmaceuticals
- 10 Upstream Processes Involved in Protein Production
- 11 Downstream Processes Involved in Protein Production
- 12 Formulation of Biopharmaceuticals
- 13 Quality and Compliance Systems
- 14 Intellectual Property Issues for Scientists
- Bibliography
- Index